Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sentinel Lymph Node Mapping with Double Tracer and Double Injection Sites in Early-Stage Endometrium Cancer

NCT06163963 is registered in ClinicalTrials.gov with Istanbul University as lead sponsor.

NCT NCT06163963
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06163963 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sentinel Lymph Node Mapping with Double Tracer and Double Injection Sites in Early-Stage Endometrium Cancer
Lead sponsor
Istanbul University
Phase
Not applicable
Overall status
Unknown status
Start date
July 1, 2023
Completion date
May 31, 2026
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endometrial cancer, sentinel lymph node